LAMP2 (P13473) variants and mutations
LAMP2 (also known as P13473) is a human protein-coding gene encoding a lysosome-associated membrane glycoprotein 2 protein. It supports lysosomal membrane integrity, autophagic cargo delivery, and lysosome-mediated turnover, with particularly important roles in heart and skeletal muscle. Loss-of-function variants cause X-linked Danon disease, typically with hypertrophic cardiomyopathy, skeletal myopathy, and variable intellectual disability. This analysis covers 670 LAMP2 variants and mutations. Of these, 74% have computational variant effect predictions. Disease context includes Danon disease, Abnormality of the cardiovascular system, and hypertrophic cardiomyopathy. Example LAMP2 variants include M1I, M1L, and M1T.
Variant analysis overview
- Gene: LAMP2
- Protein: P13473
- UniProt accession: P13473
- Organism: Homo sapiens
- Variants analyzed: 670
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 477 unspecified-consequence records; 1 stop retained variant; 2 stop lost; 67 synonymous variants; 104 missense variants; 5 stop-gained variants; 7 frameshift variants; 3 in-frame deletions; 1 splice-region variants; 3 substitution
- Prediction scores: 495 variants have prediction scores (74% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Danon disease, Abnormality of the cardiovascular system, hypertrophic cardiomyopathy, dilated cardiomyopathy, cardiomyopathy, Pigmentary retinopathy, isolated noncompaction of the ventricular myocardium, familial hypertrophic cardiomyopathy, Intellectual disability, neoplasm, hepatocellular carcinoma, familial isolated dilated cardiomyopathy.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 26 post-translational modification sites.
- Structural context: 78 variants have structural context.
- PTM context: 32 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable LAMP2 variants
Examples include M1I, M1L, M1T, C3S, C3Y, F4L, R5C, R5H. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs2147294924, ClinGen CA414398143, ClinVar RCV001528125, MetaLR 0.21, MetaSVM -0.88, Likely pathogenic, Danon disease
- M1L (p.Met1Leu), rs1556124149, ClinGen CA414398164, ClinVar RCV000512988, ClinVar RCV006463201, MetaLR 0.17, MetaSVM -0.90, Pathogenic, Cardiovascular phenotype; Danon disease
- M1T (p.Met1Thr), rs2520948481, ClinGen CA414398157, ClinVar RCV003228085, Likely pathogenic, Danon disease
- C3S (p.Cys3Ser), rs730880489, ClinGen CA335014954, ClinVar RCV002376348, ClinVar RCV003100077, REVEL 0.12, AlphaMissense 0.11, Uncertain significance, Cardiovascular phenotype; Danon disease
- C3Y (p.Cys3Tyr), rs730880489, ClinGen CA333700, ClinVar RCV000157979, TOPMed rs730880489, AlphaMissense 0.11, MetaLR 0.20, Uncertain significance, not provided
- F4L (p.Phe4Leu), rs1375151119, ClinGen CA414398094, ClinVar RCV001317122, ClinVar RCV005405571, REVEL 0.04, CADD 17.60, Uncertain significance, Cardiovascular phenotype; Danon disease
- R5C (p.Arg5Cys), rs2147294900, ClinGen CA414398067, ClinVar RCV001360992, NCI-TCGA TCGA novel, REVEL 0.22, CADD 25.50, Uncertain significance, Danon disease
- R5H (p.Arg5His), Ensembl rs1921666685, Uncertain significance
- R5L (p.Arg5Leu), rs1921666685, ClinGen CA414398058, ClinVar RCV001799286, ClinVar RCV002544359, AlphaMissense 0.20, MetaLR 0.23, Uncertain significance, Cardiomyopathy; Danon disease
- R5S (p.Arg5Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L6H (p.Leu6His), cosmic curated COSV10632
- F7L (p.Phe7Leu), rs1921666449, ClinGen CA414398025, ClinVar RCV004513483, gnomAD rs1921666449, AlphaMissense 0.25, MetaLR 0.06, Likely benign, Cardiovascular phenotype
- P8L (p.Pro8Leu), rs878854484, ClinGen CA10583929, cosmic curated COSV52352, ClinVar RCV000234637, REVEL 0.09, AlphaMissense 0.10, Conflicting interpretations, Cardiovascular phenotype; not provided; Danon disease
- P8Q (p.Pro8Gln), cosmic curated COSV52356
- P8R (p.Pro8Arg), rs878854484, ClinGen CA414398000, NCI-TCGA Cosmic COSV5235, AlphaMissense 0.10, MetaLR 0.23, Uncertain significance, not provided
- V9A (p.Val9Ala), Ensembl rs1022817972, Uncertain significance, Danon disease
- V9L (p.Val9Leu), rs1921665698, ClinGen CA414397990, ClinVar RCV001337296, ClinVar RCV003169581, REVEL 0.02, CADD 14.20, Uncertain significance, Cardiovascular phenotype; Danon disease
- P10L (p.Pro10Leu), rs769378984, ClinGen CA10505375, ClinVar RCV000805144, ClinVar RCV002440711, REVEL 0.07, CADD 18.60, Conflicting interpretations, Cardiovascular phenotype; Danon disease
- P10S (p.Pro10Ser), gnomAD rs1246273107, REVEL 0.02, CADD 10.40
- G11A (p.Gly11Ala), TOPMed rs3180515, gnomAD rs3180515, Likely benign
- G11V (p.Gly11Val), rs3180515, ClinGen CA176530, ClinVar RCV000157283, ClinVar RCV000816392, REVEL 0.22, CADD 22.40, Conflicting interpretations, Cardiovascular phenotype; not provided; Danon disease
- S12A (p.Ser12Ala), ESP rs367914423, ExAC rs367914423, TOPMed rs367914423, gnomAD rs367914423
- S12L (p.Ser12Leu), NCI-TCGA Cosmic COSV5235, cosmic curated COSV52352, Variant assessed as somatic; moderate impact.
- S12P (p.Ser12Pro), ESP rs367914423, ExAC rs367914423, TOPMed rs367914423, gnomAD rs367914423, REVEL 0.13, CADD 19.30
- S12T (p.Ser12Thr), ESP rs367914423, ExAC rs367914423, TOPMed rs367914423, gnomAD rs367914423
- G13E (p.Gly13Glu), Ensembl rs1569374472, REVEL 0.08, CADD 16.70
- G13W (p.Gly13Trp), Ensembl rs12853266
- L14H (p.Leu14His), cosmic curated COSV10721
- L14I (p.Leu14Ile), NCI-TCGA Cosmic COSV5235, cosmic curated COSV52354, Variant assessed as somatic; moderate impact.
- L14P (p.Leu14Pro), TOPMed rs1439353229
- V17F (p.Val17Phe), rs777718603, ClinVar RCV005405024, ExAC rs777718603, TOPMed rs777718603, REVEL 0.01, CADD 8.61, Likely benign, not specified
- V17I (p.Val17Ile), rs777718603, ClinGen CA10505372, ClinVar RCV001997230, ClinVar RCV002334962, REVEL 0.02, CADD 5.88, Uncertain significance, Danon disease; Cardiovascular phenotype
- C18* (p.Cys18Ter), rs2147294814, ClinGen CA414397829, ClinVar RCV001893587, Ensembl rs2147294814, Pathogenic
- C18R (p.Cys18Arg), rs2520947926, ClinGen CA414397834, ClinVar RCV003622203, Uncertain significance, Danon disease
- C18S (p.Cys18Ser), Ensembl rs1602547532
- L19R (p.Leu19Arg), rs397516745, ClinGen CA134140, ClinVar RCV000037421, Ensembl rs397516745, AlphaMissense 0.34, MetaLR 0.27, Uncertain significance, not specified
- V20G (p.Val20Gly), rs1921661568, ClinGen CA414397818, ClinVar RCV001211314, Ensembl rs1921661568, AlphaMissense 0.09, MetaLR 0.18, Uncertain significance, Danon disease
- V20S (p.Val20Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L21=, NCI-TCGA Cosmic COSV5235, Variant assessed as somatic; low impact.
- L21M (p.Leu21Met), cosmic curated COSV99568
- G22* (p.Gly22Ter), rs2147294800, ClinGen CA414397805, ClinVar RCV001783550, Ensembl rs2147294800, Pathogenic
- A23D (p.Ala23Asp), NCI-TCGA Cosmic COSV5235, cosmic curated COSV52352, REVEL 0.29, CADD 20.30, Variant assessed as somatic; moderate impact.
- V24A (p.Val24Ala), rs2520913653, ClinGen CA414403804, ClinVar RCV002462470, REVEL 0.02, CADD 5.40, Uncertain significance, not provided
- R25* (p.Arg25Ter), rs2520913421, ClinGen CA2580100339, ClinVar RCV003055563, Pathogenic
- R25P (p.Arg25Pro), rs750118236, ClinGen CA414403801, ClinVar RCV004513485, REVEL 0.13, CADD 0.28, Likely benign, Cardiovascular phenotype
- R25Q (p.Arg25Gln), rs750118236, ClinGen CA10505348, ClinVar RCV000429271, ClinVar RCV000770585, REVEL 0.07, CADD 0.01, Conflicting interpretations, Cardiovascular phenotype; not specified; Cardiomyopathy
- R25W (p.Arg25Trp), rs730880478, ClinGen CA333632, ClinVar RCV000157960, ClinVar RCV000621632, REVEL 0.12, CADD 22.60, Uncertain significance, Cardiovascular phenotype; not specified; not provided
- Y27* (p.Tyr27Ter), NCI-TCGA Cosmic COSV9956, cosmic curated COSV99568, CADD 22.50, Variant assessed as somatic; high impact.
- Y27C (p.Tyr27Cys), rs1449153826, ClinGen CA414403789, NCI-TCGA Cosmic COSV5235, cosmic curated COSV52353, REVEL 0.19, AlphaMissense 0.10, Uncertain significance, Danon disease
- Y27F (p.Tyr27Phe), rs1449153826, ClinGen CA414403790, ClinVar RCV003846456, AlphaMissense 0.10, MetaLR 0.11, Uncertain significance, Danon disease
- Y27H (p.Tyr27His), cosmic curated COSV10801, REVEL 0.05, CADD 4.91
- Y27S (p.Tyr27Ser), gnomAD rs1449153826, REVEL 0.15, AlphaMissense 0.10, Uncertain significance
- A28V (p.Ala28Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L29S (p.Leu29Ser), rs2520913509, ClinGen CA414403776, ClinVar RCV002942954, REVEL 0.27, CADD 23.50, Uncertain significance, Danon disease
- E30* (p.Glu30Ter), rs2520913492, ClinGen CA414403770, ClinVar RCV003623219, CADD 37.00, Pathogenic
- N32D (p.Asn32Asp), rs367625418, ClinGen CA335014097, ClinVar RCV002635928, ESP rs367625418, REVEL 0.06, CADD 13.70, Uncertain significance, Danon disease
- N32S (p.Asn32Ser), gnomAD rs1381065572, REVEL 0.05, CADD 8.31
- L33* (p.Leu33Ter), rs2147287668, ClinGen CA414403749, ClinVar RCV001688090, Ensembl rs2147287668, Benign
- T34A (p.Thr34Ala), ExAC rs778191463, gnomAD rs778191463, REVEL 0.08, CADD 11.30
- D35N (p.Asp35Asn), NCI-TCGA TCGA novel, REVEL 0.06, CADD 1.76, Variant assessed as somatic; moderate impact.
- S36* (p.Ser36Ter), rs2147287657, ClinGen CA414403727, ClinVar RCV001799285, Ensembl rs2147287657, Pathogenic
- S36N (p.Ser36Asn), rs773525538, Conflicting interpretations
- E37* (p.Glu37Ter), rs2520913315, ClinGen CA414403723, ClinVar RCV002455582, CADD 29.00, Pathogenic
- A39V (p.Ala39Val), cosmic curated COSV10721, TOPMed rs866456239, gnomAD rs866456239, REVEL 0.05, CADD 4.45
- T40P (p.Thr40Pro), cosmic curated COSV52354
- C41* (p.Cys41Ter), rs1921109201, ClinGen CA414403691, ClinVar RCV003510192, CADD 36.00, Pathogenic
- C41W (p.Cys41Trp), Ensembl rs1921109201
- L42R (p.Leu42Arg), gnomAD rs1439051161, REVEL 0.61, CADD 26.80
- Y43* (p.Tyr43Ter), rs2520913146, ClinGen CA414403677, ClinVar RCV002941902, CADD 35.00, Pathogenic
- A44T (p.Ala44Thr), gnomAD rs1378378776, REVEL 0.39, CADD 25.50
- W46* (p.Trp46Ter), rs1271031981, ClinGen CA414403655, ClinVar RCV000679872, Ensembl rs1271031981, CADD 36.00, Pathogenic
- W46C (p.Trp46Cys), NCI-TCGA Cosmic COSV9956, cosmic curated COSV99568, Variant assessed as somatic; moderate impact.
- Q47* (p.Gln47Ter), rs2147287624, ClinGen CA414403653, ClinVar RCV001594455, ClinVar RCV001871756, CADD 36.00, Pathogenic
- Q47H (p.Gln47His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q47P (p.Gln47Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M48I (p.Met48Ile), NCI-TCGA TCGA novel, REVEL 0.12, CADD 24.40, Likely benign, Cardiovascular phenotype
- V52A (p.Val52Ala), NCI-TCGA Cosmic COSV9956, cosmic curated COSV99568, REVEL 0.23, CADD 23.00, Variant assessed as somatic; moderate impact.
- V52I (p.Val52Ile), cosmic curated COSV10801, REVEL 0.04, CADD 4.99
- R53C (p.Arg53Cys), rs752321157, ClinGen CA10505344, cosmic curated COSV10874, ClinVar RCV000400396, REVEL 0.12, CADD 15.40, Benign/Likely benign, Cardiovascular phenotype; Danon disease
- R53H (p.Arg53His), rs397516735, ClinGen CA134071, ClinVar RCV000037406, ClinVar RCV001521516, REVEL 0.01, CADD 0.16, Conflicting interpretations, Cardiovascular phenotype; not specified; Danon disease
- R53L (p.Arg53Leu), rs397516735, ClinGen CA335014093, ClinVar RCV002624719, 1000Genomes rs397516735, REVEL 0.06, CADD 0.17, Uncertain significance, Danon disease
- Y54H (p.Tyr54His), cosmic curated COSV10456, REVEL 0.60, CADD 25.60
- T56A (p.Thr56Ala), rs2147287602, ClinGen CA414403588, ClinVar RCV001889890, Ensembl rs2147287602, REVEL 0.12, CADD 20.50, Uncertain significance, Danon disease
- T57A (p.Thr57Ala), TOPMed rs1259106557, REVEL 0.04, CADD 17.50
- N58S (p.Asn58Ser), TOPMed rs1294027053, gnomAD rs1294027053, REVEL 0.04, CADD 1.09
- T60A (p.Thr60Ala), rs1207512652, ClinGen CA414403559, ClinVar RCV001965639, gnomAD rs1207512652, REVEL 0.04, CADD 6.37, Uncertain significance, Danon disease
- T60N (p.Thr60Asn), cosmic curated COSV10954, REVEL 0.02, CADD 0.13
- Y61* (p.Tyr61Ter), rs397516736, ClinGen CA134078, ClinVar RCV000037407, ClinVar RCV001387423, Pathogenic
- Y61F (p.Tyr61Phe), Ensembl rs926979928
- K62* (p.Lys62Ter), rs2520912530, ClinGen CA2580612467, ClinVar RCV003314467, Likely pathogenic
- T63I (p.Thr63Ile), rs1358581771, ClinGen CA414403526, ClinVar RCV000794904, ClinVar RCV002406740, REVEL 0.01, CADD 7.32, Conflicting interpretations, Cardiovascular phenotype; Danon disease
- V64G (p.Val64Gly), ExAC rs769883128, REVEL 0.16, CADD 5.62
- V64I (p.Val64Ile), gnomAD rs1921058018, REVEL 0.02, CADD 5.92
- S67L (p.Ser67Leu), rs2520908485, ClinGen CA414403503, ClinVar RCV002610903, REVEL 0.09, CADD 16.00, Uncertain significance, Danon disease
- S67P (p.Ser67Pro), rs2147286966, ClinGen CA414403506, ClinVar RCV001898353, ClinVar RCV003166997, REVEL 0.05, CADD 5.49, Uncertain significance, Cardiovascular phenotype; Danon disease
- D68E (p.Asp68Glu), rs376215728, ClinGen CA10505334, ClinVar RCV000429123, ClinVar RCV000638580, REVEL 0.04, CADD 0.43, Conflicting interpretations, Cardiovascular phenotype; not specified; Danon disease
- D68G (p.Asp68Gly), Ensembl rs113529754
- D68H (p.Asp68His), cosmic curated COSV10505
- H69N (p.His69Asn), cosmic curated COSV99568, REVEL 0.02, CADD 0.06
- H69R (p.His69Arg), ExAC rs771157957, gnomAD rs771157957, REVEL 0.00, CADD 0.00
- H69Y (p.His69Tyr), rs776875696, ClinGen CA10505333, ClinVar RCV001218537, ClinVar RCV002418750, REVEL 0.02, CADD 0.00, Uncertain significance, Cardiovascular phenotype; Danon disease
- G70V (p.Gly70Val), rs1340367353, ClinGen CA414403481, ClinVar RCV001730307, ClinVar RCV002421249, REVEL 0.01, CADD 3.74, Uncertain significance, Cardiovascular phenotype; Danon disease
- T71A (p.Thr71Ala), rs747390282, ClinGen CA10505331, ClinVar RCV003623572, ExAC rs747390282, REVEL 0.01, CADD 2.23, Uncertain significance, Danon disease
- T71I (p.Thr71Ile), rs2520908353, ClinGen CA414403475, ClinVar RCV002740151, REVEL 0.02, CADD 8.67, Uncertain significance, Danon disease
- T71S (p.Thr71Ser), rs2520908353, ClinGen CA414403474, ClinVar RCV002999832, Likely benign, Danon disease
- V72M (p.Val72Met), rs778193991, ClinGen CA10505330, ClinVar RCV000608584, ClinVar RCV001293166, REVEL 0.06, CADD 20.50, Uncertain significance, not specified; Danon disease; Primary dilated cardiomyopathy
- T73I (p.Thr73Ile), ExAC rs758621669, gnomAD rs758621669, REVEL 0.30, CADD 24.40
- Y74* (p.Tyr74Ter), Ensembl rs2147286913, Pathogenic
- I78V (p.Ile78Val), rs748676358, ClinGen CA10505328, ClinVar RCV000808198, ExAC rs748676358, REVEL 0.02, CADD 0.08, Likely benign, Danon disease
- C79W (p.Cys79Trp), rs2147286906, ClinGen CA414403381, ClinVar RCV001772371, Ensembl rs2147286906, REVEL 0.51, CADD 23.90, Uncertain significance, not provided
- D81V (p.Asp81Val), gnomAD rs1267770607, REVEL 0.15, CADD 22.30
- Q83* (p.Gln83Ter), rs1236204882, NCI-TCGA Cosmic COSV5235, cosmic curated COSV52352, Ensembl rs1236204882, Variant assessed as somatic; high impact.
- N84S (p.Asn84Ser), rs2147286887, ClinGen CA414403329, ClinVar RCV001904049, Ensembl rs2147286887, REVEL 0.02, CADD 1.64, Uncertain significance, Danon disease
- G85S (p.Gly85Ser), rs371149731, ClinGen CA16621191, ClinVar RCV000480236, ClinVar RCV002431391, REVEL 0.03, CADD 11.20, Uncertain significance, Cardiovascular phenotype; not specified; Danon disease
- K87R (p.Lys87Arg), rs1556112678, ClinGen CA414403300, ClinVar RCV002437159, REVEL 0.01, CADD 2.96, Uncertain significance, Cardiovascular phenotype
- K87T (p.Lys87Thr), rs1556112678, ClinGen CA414403301, ClinVar RCV000522679, ClinVar RCV001219126, REVEL 0.02, CADD 2.64, Conflicting interpretations, Cardiovascular phenotype; not provided; Danon disease
- I88T (p.Ile88Thr), rs1569371283, ClinGen CA414403284, ClinVar RCV000699076, Ensembl rs1569371283, AlphaMissense 0.67, MetaLR 0.13, Uncertain significance, Danon disease
- A89G (p.Ala89Gly), gnomAD rs1321639564, REVEL 0.05, CADD 12.60
- V90A (p.Val90Ala), NCI-TCGA Cosmic COSV5235, cosmic curated COSV52352, Variant assessed as somatic; moderate impact.
- G93R (p.Gly93Arg), rs727504953, ExAC rs727504953, TOPMed rs727504953, gnomAD rs727504953, REVEL 0.12, CADD 12.10, Conflicting interpretations, not specified; Cardiovascular phenotype; Cardiomyopathy
- P94A (p.Pro94Ala), rs2147286839, ClinGen CA414403223, ClinVar RCV002016498, ClinVar RCV005654939, AlphaMissense 0.06, MetaLR 0.03, Conflicting interpretations, Cardiovascular phenotype; Danon disease
- P94H (p.Pro94His), rs1348977041, ClinGen CA414403220, ClinVar RCV002441792, TOPMed rs1348977041, REVEL 0.04, AlphaMissense 0.08, Uncertain significance, Cardiovascular phenotype
- P94L (p.Pro94Leu), rs1348977041, ClinGen CA414403218, ClinVar RCV003857317, TOPMed rs1348977041, AlphaMissense 0.08, MetaLR 0.05, Uncertain significance, Cardiovascular phenotype; Danon disease
- G95D (p.Gly95Asp), ExAC rs755790073, TOPMed rs755790073, gnomAD rs755790073, REVEL 0.17, CADD 21.50, Uncertain significance
- G95V (p.Gly95Val), rs755790073, ClinGen CA10505324, ClinVar RCV001928539, ClinVar RCV002441029, REVEL 0.14, CADD 16.40, Uncertain significance, Danon disease; Cardiovascular phenotype
- F96L (p.Phe96Leu), rs1421127800, ClinGen CA414403211, ClinVar RCV001241789, TOPMed rs1421127800, AlphaMissense 0.70, MetaLR 0.05, Uncertain significance, Danon disease
- W98* (p.Trp98Ter), rs397516740, ClinGen CA134089, ClinVar RCV000037412, ClinVar RCV000157963, Pathogenic
- W98L (p.Trp98Leu), cosmic curated COSV52354
- W98X, rs876657696, Pathogenic
- A100V (p.Ala100Val), rs397516741, ClinGen CA134096, ClinVar RCV000037413, ClinVar RCV001518789, REVEL 0.02, CADD 3.11, Benign/Likely benign, Cardiovascular phenotype; not specified; not provided
- F102L (p.Phe102Leu), gnomAD rs1369743540, REVEL 0.31, CADD 23.90
- A105T (p.Ala105Thr), rs2147286818, ClinGen CA414403050, ClinVar RCV003150612, ClinVar RCV003621684, REVEL 0.01, CADD 0.18, Uncertain significance, Cardiomyopathy; Danon disease
- A106S (p.Ala106Ser), rs1305798857, ClinGen CA414403036, ClinVar RCV001866547, ClinVar RCV003225194, REVEL 0.01, CADD 0.36, Uncertain significance, not provided; Danon disease
- A106T (p.Ala106Thr), rs1305798857, ClinGen CA414403039, ClinVar RCV001367042, ClinVar RCV002322343, REVEL 0.02, CADD 1.43, Uncertain significance, Cardiovascular phenotype; Danon disease
- S107C (p.Ser107Cys), rs730880497, ClinGen CA333716, ClinVar RCV000157990, ClinVar RCV000621428, REVEL 0.12, CADD 23.10, Conflicting interpretations, Cardiovascular phenotype; not provided; Danon disease
- S107F (p.Ser107Phe), NCI-TCGA Cosmic COSV5235, cosmic curated COSV52352, REVEL 0.12, CADD 23.30, Variant assessed as somatic; moderate impact.
- T108A (p.Thr108Ala), ExAC rs751526532, gnomAD rs751526532, REVEL 0.04, CADD 0.22
- Y109* (p.Tyr109Ter), rs1397410765, ClinGen CA414402987, ClinVar RCV001783587, Ensembl rs1397410765, Pathogenic
- Y109H (p.Tyr109His), NCI-TCGA Cosmic COSV5235, cosmic curated COSV52353, Variant assessed as somatic; moderate impact.
- I111T (p.Ile111Thr), gnomAD rs1162557907, REVEL 0.22, CADD 18.80
- I111V (p.Ile111Val), rs762218821, ClinGen CA10505321, ClinVar RCV001871775, ClinVar RCV005590016, REVEL 0.08, CADD 9.57, Conflicting interpretations, Cardiovascular phenotype; Danon disease
- D112G (p.Asp112Gly), ExAC rs759658269, gnomAD rs759658269, REVEL 0.11, CADD 16.30
- D112H (p.Asp112His), Ensembl rs1921044662
- D112N (p.Asp112Asn), rs1921044662, ClinGen CA414402960, ClinVar RCV003509915, cosmic curated COSV10874, AlphaMissense 0.16, MetaLR 0.06, Uncertain significance, Danon disease
- S113C (p.Ser113Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S113N (p.Ser113Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S113R (p.Ser113Arg), rs147369153, ClinGen CA414402933, cosmic curated COSV10632, ClinVar RCV000520142, REVEL 0.09, CADD 12.80, Conflicting interpretations, Cardiovascular phenotype; not provided; Danon disease
- V114I (p.Val114Ile), rs377652722, ClinGen CA333610, cosmic curated COSV52356, ClinVar RCV001532707, REVEL 0.14, CADD 14.10, Conflicting interpretations, Cardiovascular phenotype; not provided; Danon disease
- S115* (p.Ser115Ter), rs950725039, ClinGen CA414402920, ClinVar RCV002221763, Ensembl rs950725039, AlphaMissense 0.09, MetaLR 0.11, Pathogenic
- S115L (p.Ser115Leu), rs950725039, ClinGen CA335014012, cosmic curated COSV52356, ClinVar RCV003031995, AlphaMissense 0.09, MetaLR 0.11, Uncertain significance, Danon disease
- S117F (p.Ser117Phe), TOPMed rs1921043793
- Y118C (p.Tyr118Cys), ExAC rs760953845, gnomAD rs760953845
- N119S (p.Asn119Ser), ExAC rs773248859, gnomAD rs773248859, REVEL 0.32, CADD 24.40
- T120A (p.Thr120Ala), Ensembl rs1921042918, REVEL 0.22, AlphaMissense 0.11
- T120P (p.Thr120Pro), rs1921042918, ClinGen CA414402860, ClinVar RCV002957736, AlphaMissense 0.11, MetaLR 0.15, Uncertain significance, Danon disease
- G121D (p.Gly121Asp), ExAC rs772520416, gnomAD rs772520416, REVEL 0.03, CADD 13.10
- G121V (p.Gly121Val), NCI-TCGA Cosmic COSV5235, cosmic curated COSV52355, Variant assessed as somatic; moderate impact.
- D122N (p.Asp122Asn), rs730880480, ClinGen CA333640, ClinVar RCV000585174, ClinVar RCV001308958, REVEL 0.24, CADD 23.80, Uncertain significance, not provided; Danon disease
- N123Y (p.Asn123Tyr), TOPMed rs1921042232, Uncertain significance, Danon disease
- T124I (p.Thr124Ile), rs397516744, ClinGen CA134118, ClinVar RCV000037417, ClinVar RCV003343612, REVEL 0.06, CADD 8.53, Uncertain significance, Cardiovascular phenotype; not specified; Danon disease
- T125A (p.Thr125Ala), rs748494547, ClinGen CA10505316, ClinVar RCV001360040, ExAC rs748494547, REVEL 0.10, CADD 12.10, Uncertain significance, Danon disease
- F126L (p.Phe126Leu), Ensembl rs1921041004, REVEL 0.48, CADD 26.80, Uncertain significance, Danon disease
- P127L (p.Pro127Leu), rs1200950486, ClinGen CA414402751, ClinVar RCV001035717, ClinVar RCV001759724, REVEL 0.72, CADD 27.00, Uncertain significance, Danon disease; not provided
- P127R (p.Pro127Arg), rs1200950486, ClinGen CA414402753, ClinVar RCV001799287, ClinVar RCV001868906, REVEL 0.79, CADD 26.20, Uncertain significance, Cardiovascular phenotype; Cardiomyopathy; not specified
- P127S (p.Pro127Ser), rs2147286737, ClinGen CA414402756, ClinVar RCV001754969, Ensembl rs2147286737, AlphaMissense 0.20, MetaLR 0.76, Uncertain significance, not provided
- D128Y (p.Asp128Tyr), rs2520906874, ClinGen CA414402749, ClinVar RCV003623662, Uncertain significance, Danon disease
- A129T (p.Ala129Thr), rs149276836, ClinGen CA243249, ClinVar RCV000724029, ClinVar RCV001079583, REVEL 0.34, CADD 26.20, Conflicting interpretations, Cardiovascular phenotype; not specified; Cardiomyopathy
- E130Q (p.Glu130Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D131H (p.Asp131His), NCI-TCGA TCGA novel, REVEL 0.05, CADD 16.80, Variant assessed as somatic; moderate impact.
- G133E (p.Gly133Glu), rs2147283120, ClinGen CA414402396, ClinVar RCV001977481, Ensembl rs2147283120, AlphaMissense 0.12, MetaLR 0.19, Uncertain significance, Danon disease
- I134T (p.Ile134Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V137A (p.Val137Ala), TOPMed rs1679458769, REVEL 0.12, CADD 14.80
- V137L (p.Val137Leu), rs2147283117, ClinGen CA414402366, ClinVar RCV001980591, Ensembl rs2147283117, REVEL 0.07, CADD 12.40, Uncertain significance, Danon disease
- D138G (p.Asp138Gly), rs2520888843, ClinGen CA414402352, ClinVar RCV003140300, REVEL 0.04, CADD 0.04, Uncertain significance, Danon disease
- E139K (p.Glu139Lys), rs373007615, ClinGen CA10505304, ClinVar RCV002261663, ClinVar RCV003621616, REVEL 0.01, CADD 0.45, Conflicting interpretations, not provided; Danon disease
- E139V (p.Glu139Val), rs1602536486, ClinGen CA414402339, ClinVar RCV000813835, Ensembl rs1602536486, AlphaMissense 0.14, MetaLR 0.11, Uncertain significance, Danon disease
- L141W (p.Leu141Trp), NCI-TCGA Cosmic COSV9956, cosmic curated COSV99568, Variant assessed as somatic; moderate impact.
- A142P (p.Ala142Pro), rs2058610678, ClinGen CA414402313, ClinVar RCV001214059, Ensembl rs2058610678, AlphaMissense 0.11, MetaLR 0.10, Uncertain significance, Danon disease
- A142V (p.Ala142Val), rs2520888772, ClinGen CA414402306, ClinVar RCV002736435, Uncertain significance, Danon disease
- R144I (p.Arg144Ile), cosmic curated COSV52351, ExAC rs752509876
Public LAMP2 analysis runs
- LAMP2 analysis run — LAMP2 (670 variants) — completed 2026-08-19